Targeting glutamine transport to suppress melanoma cell growth
暂无分享,去创建一个
J. Rasko | N. Haass | C. Bailey | J. Holst | Jessamy Tiffen | K. A. Beaumont | D. Sharp | M. Jormakka | N. Otte | R. Ryan | Kimberley A. Beaumont | J. Font | Qian Wang | M. Geldermalsen
[1] M. Gleave,et al. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development. , 2013, Journal of the National Cancer Institute.
[2] John M. Asara,et al. Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.
[3] Yigong Shi,et al. A proposed role for glutamine in cancer cell growth through acid resistance , 2013, Cell Research.
[4] P. Massion,et al. SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival , 2012, Clinical Cancer Research.
[5] E. Gottlieb,et al. Glutaminolysis activates Rag-mTORC1 signaling. , 2012, Molecular cell.
[6] C. De Virgilio,et al. Leucyl-tRNA synthetase controls TORC1 via the EGO complex. , 2012, Molecules and Cells.
[7] Sunghoon Kim,et al. Leucyl-tRNA Synthetase Is an Intracellular Leucine Sensor for the mTORC1-Signaling Pathway , 2012, Cell.
[8] P. Hersey,et al. Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737 , 2011, Clinical Cancer Research.
[9] Roberto Zoncu,et al. mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase , 2011, Science.
[10] Qian Wang,et al. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. , 2011, Cancer research.
[11] D. Sabatini,et al. Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. , 2011, Cancer cell.
[12] C. Thompson,et al. Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.
[13] D. Sabatini,et al. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.
[14] Y. Kanai,et al. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line. , 2009, Cancer letters.
[15] Jeffrey P. MacKeigan,et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.
[16] A. Santiago-Walker,et al. Melanocytes: From Morphology to Application , 2009, Skin Pharmacology and Physiology.
[17] D. Elder,et al. CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations , 2009, Oncogene.
[18] Y. Kanai,et al. L‐type amino‐acid transporter 1 as a novel biomarker for high‐grade malignancy in prostate cancer , 2009, Pathology international.
[19] N. Sunaga,et al. l‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms , 2008, Cancer science.
[20] Hong Wu,et al. Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas , 2008, Molecular Cancer Therapeutics.
[21] H. Iijima,et al. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. , 2008, Pathology, research and practice.
[22] T. P. Neufeld,et al. Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.
[23] N. Sunaga,et al. Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer , 2008, British Journal of Cancer.
[24] M. Herlyn,et al. In vitro three-dimensional tumor microenvironment models for anticancer drug discovery , 2008, Expert opinion on drug discovery.
[25] M. Herlyn,et al. The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel , 2008, Clinical Cancer Research.
[26] K. Flaherty,et al. Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels , 2007, British Journal of Cancer.
[27] D. Schadendorf,et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.
[28] Keith T Flaherty,et al. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases , 2006, Molecular Cancer Therapeutics.
[29] Yixin Wang,et al. Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions , 2005, Clinical Cancer Research.
[30] B. Fuchs,et al. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? , 2005, Seminars in cancer biology.
[31] M. Hemler,et al. Metabolic Activation-related CD147-CD98 Complex*S , 2005, Molecular & Cellular Proteomics.
[32] C. Grewer,et al. New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+‐dependent anion leak , 2004, The Journal of physiology.
[33] M. Hediger,et al. The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects , 2004, Pflügers Archiv.
[34] P. Scardino,et al. Expression of neutral amino acid transporter ASCT2 in human prostate. , 2003, Anticancer research.
[35] R. Paules,et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.
[36] T. Golub,et al. The Immunosuppressant Rapamycin Mimics a Starvation-Like Signal Distinct from Amino Acid and Glucose Deprivation , 2002, Molecular and Cellular Biology.
[37] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[38] R. Vandenberg,et al. Niflumic acid modulates uncoupled substrate‐gated conductances in the human glutamate transporter EAAT4 , 2001, The Journal of physiology.
[39] U. Zangemeister‐Wittke,et al. p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[40] L. Shantz,et al. Leucine Regulates Translation of Specific mRNAs in L6 Myoblasts through mTOR-mediated Changes in Availability of eIF4E and Phosphorylation of Ribosomal Protein S6* , 1999, The Journal of Biological Chemistry.
[41] J. Rasko,et al. The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Shoemaker,et al. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family , 1998, Nature.
[43] Eiji Takeda,et al. Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)* , 1998, The Journal of Biological Chemistry.
[44] J. Avruch,et al. Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism* , 1998, The Journal of Biological Chemistry.
[45] V. Ganapathy,et al. Cloning of the Sodium-dependent, Broad-scope, Neutral Amino Acid Transporter Bo from a Human Placental Choriocarcinoma Cell Line* , 1996, The Journal of Biological Chemistry.
[46] K. Flaherty,et al. Targeting the RAS pathway in melanoma. , 2012, Trends in molecular medicine.
[47] L. Tanoue. Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths , 2012 .
[48] S. Bröer,et al. Amino acid transport across mammalian intestinal and renal epithelia. , 2008, Physiological reviews.
[49] D. Shennan,et al. Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells. , 2008, Oncology reports.
[50] J. Mcgivan,et al. The transport of glutamine into mammalian cells. , 2007, Frontiers in bioscience : a journal and virtual library.
[51] K. Flaherty,et al. An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. , 2007, Cancer research.
[52] 福原 大介. Protein characterization of Na[+] -independent system L amino acid transporter 3 in mice : a potential role in supply of branched-chain amino acids under nutrient starvation , 2006 .
[53] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[54] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.